Back
15
Day Range
$11.83
$12.21
52-Week Range
$11.11
$27.63
Volume
977,668
50D / 200D Avg
$13.78
/
$18.32
Prev Close
$12.02
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -8.5 | 0.4 |
| P/B | 2.4 | 2.9 |
| ROE % | -26.3 | 3.7 |
| Net Margin % | -40.4 | 3.8 |
| Rev Growth 5Y % | 16.7 | 10.0 |
| D/E | 0.3 | 0.2 |
Key Takeaways
Revenue grew 16.70% annually over 5 years — strong growth
Debt/Equity of 0.30 — conservative balance sheet
Generating 12.46M in free cash flow
PEG of 0.28 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6.59%
Capital efficient — spends only 0.56% of revenue on capex
Growth
Revenue Growth (5Y)
16.70%
Revenue (1Y)23.29%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-26.29%
ROIC-26.45%
Net Margin-40.36%
Op. Margin-65.23%
Safety
Debt / Equity
0.30
Current Ratio2.75
Interest Coverage0.00
Valuation
P/E Ratio
-8.49
P/B Ratio2.41
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 23.29% | Revenue Growth (3Y) | 8.67% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 16.70% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 255.87M | Net Income (TTM) | -103.27M |
| ROE | -26.29% | ROA | -14.22% |
| Gross Margin | 55.74% | Operating Margin | -65.23% |
| Net Margin | -40.36% | Free Cash Flow (TTM) | 12.46M |
| ROIC | -26.45% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.30 | Current Ratio | 2.75 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -8.49 | P/B Ratio | 2.41 |
| P/S Ratio | 3.42 | PEG Ratio | 0.28 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 876.30M | Enterprise Value | 755.02M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 255.87M | 207.54M | 216.67M | 180.96M | 137.93M |
| Net Income | -103.27M | -187.12M | 40.72M | -149.19M | -100.39M |
| EPS (Diluted) | -1.41 | -2.57 | 0.54 | -2.10 | -1.43 |
| Gross Profit | 142.61M | 132.08M | 140.69M | 101.02M | 65.62M |
| Operating Income | -166.90M | -209.30M | -177.45M | -146.82M | -111.44M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 726.16M | 823.23M | 802.96M | 688.59M | 756.49M |
| Total Liabilities | 362.11M | 401.78M | 254.40M | 240.68M | 199.40M |
| Shareholders' Equity | 364.05M | 421.45M | 548.56M | 447.89M | 557.07M |
| Total Debt | 109.23M | 117.83M | 127.88M | 116.49M | 79.87M |
| Cash & Equivalents | 230.52M | 147.33M | 155.32M | 90.47M | 120.27M |
| Current Assets | 519.27M | 634.99M | 567.80M | 533.99M | 625.06M |
| Current Liabilities | 189.14M | 191.75M | 133.67M | 108.80M | 91.21M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#137 of 146
Recent Activity
Entered
Full Throttle
Mar 24, 2026